Senior insider sale
Chief Medical Officer at UROGEN PHARMA LTD. — senior position signals high conviction
$181.0K
6.09K shares
What this filing means
SCHOENBERG MARK plans to sell 6.09K shares of UROGEN PHARMA LTD. valued at approximately $181.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/9/2026ACC: 0001976408-26-000811
Officer· Chief Medical Officer
Since Jan 2019
6.09K
Shares to sell
$181.0K
Approx. market value
5K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Shares issued upon vesting of RSUs
No consideration, shares issued upon vesting of RSUs
9/8/2026
5KTotal acquired5K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/8/2026 | Shares issued upon vesting of RSUs No consideration, shares issued upon vesting of RSUs | 5K | — |
| Total | 5K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
5.22K
Market value
$142.6K
6/8/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
871.00
Market value
$38.4K
9/8/2026
Total
Units
6.09K
Value
$181.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/8/2026 | 5.22K | $142.6K | — | Completed |
| Planned — Approximate Date | ||||
9/8/2026 | 871.00 | $38.4K | Nasdaq | Planned |
| Total | 6.09K | $181.0K | ||